| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |